Prognostic factors in early-stage leiomyosarcoma of the uterus

International Journal of Gynecological Cancer

Volumn 19, Issue 3, 2009, Pages 385-390

  Pelmus, Manuela ^a   Penault Llorca, Frédérique ^b   Guillou, Louis ^c   Collin, Françoise ^d   Bertrand, Gérard ^e   Trassard, Martine ^f   Leroux, Agnès ^g   Floquet, Anne ^h   Stoeckle, Eberhard ^h   Thomas, Laurence ^h   MacGrogan, Gaëtan ^h  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b CENTRE JEAN PERRIN   (France)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

^e CENTRE PAUL PAPIN   (France)

^f CENTRE RENÉ HUGUENIN   (France)

^g CENTRE ALEXIS VAUTRIN   (France)

^h INSTITUT BERGONIÉ   (France)

Author keywords

FIGO stage; Leiomyosarcoma; Prognosis; Uterus

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; METASTASIS; MITOSIS RATE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; UTERUS LEIOMYOSARCOMA; UTERUS SARCOMA; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; UTERINE NEOPLASMS;

EID: 68149162597     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a1bfbc     Document Type: Article

References (32)

1. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
2. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535-558.
3. Blom R., Guerrieri C., Stal O., et al. Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol. 1998;68:54-61.
4. Brooks SE, Zhan M., Cote T., et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol. 2004;93:204-208.
5. Giuntoli RL, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89:460-469.
6. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer. 1993;71:1702-1709.
7. Niemann TH, Raab SS, Lenel JC, et al. p53 protein overexpression in smooth muscle tumors of the uterus. Hum Pathol. 1995;26:375-379.
8. Nordal RR, Kristensen GB, Kaern J., et al. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol. 1995;34:797-802.
9. Thigpen JT, Blessing JA, Wilbanks GD. Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus: a phase II trial of the Gynecologic Oncology Group. Am J Clin Oncol. 1986;9:18-20.
10. Thigpen T., Blessing JA, Yordan E., et al. Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol. 1996;63:120-122.
11. Tsushima K., Stanhope CR, Gaffey TA, et al. Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc. 1988;63:248-255.
12. Gadducci A., Landoni F., Sartori E., et al. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol. 1996;62:25-32.
13. Wolfson AH, Wolfson DJ, Sittler SY, et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol. 1994;52:56-62.
14. Aaro LA, Symmonds RE, Dockerty MB. Sarcoma of the uterus: a clinical and pathologic study of 177 cases. Am J Obstet Gynecol. 1966;94:101-109.
15. Gard GB, Mulvany NJ, Quinn MA. Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol. 1999;39:93-98.
16. Hannigan EV, Gomez LG. Uterine leiomyosarcoma. Am J Obstet Gynecol. 1979;134:557-564.
17. Mayerhofer K., Obermair A., Windbichler G., et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999;74:196-201.
18. Pautier P., Genestie C., Rey A., et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer. 2000;88:1425-1431.
19. Peters WA 3rd, Howard DR, Andersen WA, et al. Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol. 1994;83:1015-1020.
20. Van Dinh T., Woodruff JD. Leiomyosarcoma of the uterus. Am J Obstet Gynecol. 1982;144:817-823.
21. Kahanpaa KV, Wahlstrom T., Grohn P., et al. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol. 1986;67:417-424.
22. Larson B., Silfversward C., Nilsson B., et al. Prognostic factors in uterine leiomyosarcoma: a clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol. 1990;29: 185-191.
23. Nola M., Babic D., Ilic J., et al. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer. 1996;78:2543-2550.
24. Atkins K., Bell S., Kempson RL, et al. Myxoid smooth muscle tumors of the uterus. Mod Pathol. 2001;14:132A. Abstract 772.
25. Atkins K., Bell S., Kempson RL, et al. Epithelioid smooth muscle tumors of the uterus. Mod Pathol. 2001;14:132A. Abstract 771.
26. Coindre JM, Nguyen BB, Bonichon F., et al. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer. 1988;61:2305-2309.
27. Salazar OM, Dunne ME. The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Biol Phys. 1980;6:899-902.
28. Vardi JR, Tovell HM. Leiomyosarcoma of the uterus: clinicopathologic study. Obstet Gynecol. 1980;56:428-434.
29. Vongtama V., Karlen JR, Piver SM, et al. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri. Am J Roentgenol. 1976;126:139-147.
30. Coindre JM, Terrier P., Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869-877.
31. Silverberg SG. Leiomyosarcoma of the uterus: a clinicopathologic study. Obstet Gynecol. 1971;38:613-628.
32. Evans HL, Chawla SP, Simpson C., et al. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma: a study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 1988;62:2239-2247.